Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone Monotherapy Versus Prednisolone Plus Methotrexate in Erythema Nodosum Leprosum
NCT07806357Phase 1Completed
- Sponsor
- Chattogram Medical College
- Start
- Jun 2018
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
Phase 1, randomised trial of methotrexate in erythema nodosum leprosum (ENL) (2 arms), sponsored by Chattogram Medical College. Primary endpoint: Efficacy and Safety of Prednisolone Monotherapy Versus Prednisolone Plus Methotrexate at 18 months. Started Jun 2018; status: completed.
02
Drugs
methotrexate
03
Conditions
erythema nodosum leprosum (ENL)
Beyond the preview
Go deeper on NCT07806357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07806357.